Global NK Cell Therapy Market Size, Status and Forecast 2020-2026

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The North America natural killer cells therapeutics market share accounted for the highest share 52.4% in 2018 and is expected to continue its dominance throughout the forecast period. This is attributed to significant increase in prevalence of cancer in this region. However, the Asia market is anticipated to grow at the fastest pace, owing to increase in number of patients suffering from cancer, surge in geriatric population, and improvement in healthcare facilities. However, the complexity in regulatory frameworks regarding the approval of immunotherapy is expected to hamper the market growth.
Market Analysis and Insights: Global NK Cell Therapy Market
In 2019, the global NK Cell Therapy market size was US$ 254.8 million and it is expected to reach US$ 736.9 million by the end of 2026, with a CAGR of 16.2% during 2021-2026.
Global NK Cell Therapy Scope and Market Size
NK Cell Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global NK Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the NK Cell Therapy market is segmented into NK Cell Therapies, NK Cell Directed Antibodies, etc.
Segment by Application, the NK Cell Therapy market is segmented into Cancer, Gastrointestinal Diseases, Others, etc.
Regional and Country-level Analysis
The NK Cell Therapy market is analysed and market size information is provided by regions (countries).
The key regions covered in the NK Cell Therapy market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and NK Cell Therapy Market Share Analysis
NK Cell Therapy market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in NK Cell Therapy business, the date to enter into the NK Cell Therapy market, NK Cell Therapy product introduction, recent developments, etc.
The major vendors include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech, etc.

This report focuses on the global NK Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the NK Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech

Market segment by Type, the product can be split into

NK Cell Therapies
NK Cell Directed Antibodies
NK Cell agents took the largest market share segment, accounting for 82% and growing fastest

Market segment by Application, split into

Cancer
Gastrointestinal Diseases
Others
Cancer was the most widely used area at 66%

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global NK Cell Therapy status, future forecast, growth opportunity, key market and key players.
To present the NK Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of NK Cell Therapy are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.